Litcius/Paper detail

Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines

M. L. Caballero, Santiago Quirce

2021Journal of Investigational Allergology and Clinical Immunology39 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakAnaphylaxisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyImmunologyAllergyInfectious disease (medical specialty)DiseasePathologyOutbreakFood Allergy and Anaphylaxis ResearchAllergic Rhinitis and SensitizationDermatology and Skin Diseases
Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines | Litcius